サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1541418

ポリメラーゼ連鎖反応市場レポート：製品、エンドユーザー、地域別、2024～2032年

Polymerase Chain Reaction Market Report by Product, End User, and Region 2024-2032

出版日
発行
IMARC
ページ情報
英文 135 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
ポリメラーゼ連鎖反応市場レポート：製品、エンドユーザー、地域別、2024～2032年
出版日: 2024年08月10日
発行: IMARC
ページ情報: 英文 135 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のポリメラーゼ連鎖反応市場規模は2023年に77億米ドルに達しました。今後、IMARC Groupは、市場は2032年までに139億米ドルに達し、2024～2032年の間に6.5％の成長率（CAGR）を示すと予測しています。

ポリメラーゼ連鎖反応（PCR）は、DNAセグメントの複数のコピーを作成するために使用される分子診断技術を指します。PCR装置は、自動的かつ事前にプログラムされた手順でサンプルの温度を操作し、数百万コピーのDNAシーケンスを正確に生成するために使用されます。この技術は、結核、後天性免疫不全症候群（AIDS）、感染症、ライム病の検出に役立つ、病気を引き起こす微生物を同定し培養します。このため、遺伝学、バイオテクノロジー、分子生物学、創薬、臨床診断など、さまざまなライフサイエンス関連セグメントに幅広く応用されています。

世界のポリメラーゼ連鎖反応市場動向と促進要因

様々な感染症や遺伝性疾患の有病率の増加は、市場の成長を促進する主要要因の一つです。また、慢性疾患にかかりやすい高齢者人口が世界中で増加していることも、業界の成長を後押ししています。コロナウイルス病（COVID-19）の大流行は、正確な診断と感染の早期発見のためのPCR技術の広範な採用につながっています。PCR装置はまた、汚染のリスクやプロセス全体における人為的ミスの可能性を最小限に抑えるのに役立っています。

個別化医療や精密医療に対する需要の高まりも、市場に明るい展望をもたらしています。これらの医薬品は、PCR技術を用いて特定され開発されるオーダーメイドの治療法を提供することを目的としています。臨床診断におけるアプリケーションの増加、バイオテクノロジーセグメントにおける広範な研究開発（R&D）活動など、その他の要因も市場をさらに牽引すると予想されます。

本レポートで扱う主要質問

  • 世界のポリメラーゼ連鎖反応市場はこれまでどのように推移し、今後どのように推移していくのか？
  • COVID-19は世界のポリメラーゼ連鎖反応市場にどのような影響を与えたか？
  • 主要地域市場とは？
  • 製品別の市場内訳は？
  • エンドユーザー別の市場内訳は？
  • 業界のバリューチェーンにおける様々なステージとは？
  • 業界の主要な促進要因と課題は何か？
  • 世界のポリメラーゼ連鎖反応市場の構造と主要参入企業は？
  • 業界の競合の程度は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界のポリメラーゼ連鎖反応市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：製品別

  • 機器
    • 市場動向
    • 市場内訳：タイプ別
      • 標準PCRシステム
      • デジタルPCRシステム
      • リアルタイムPCRシステム
    • 市場予測
  • 試薬と消耗品
  • ソフトウェアとサービス

第7章 市場内訳：エンドユーザー別

  • 学術研究機関
  • 臨床診断ラボと病院
  • 製薬・バイオテクノロジー企業
  • その他

第8章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第9章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第10章 バリューチェーン分析

第11章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第12章 価格分析

第13章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Agilent Technologies Inc.
    • BD（Becton, Dickinson and Company）
    • BioMerieux（Institut Merieux SA）
    • Bio-RAD Laboratories Inc.
    • F. Hoffmann-La Roche AG
    • Fluidigm Corporation
    • Merck KGaA
    • Perkinelmer Inc.
    • Promega Corporation
    • Takara Bio Inc.
    • Thermo Fisher Scientific Inc.
図表

List of Figures

  • Figure 1: Global: Polymerase Chain Reaction Market: Major Drivers and Challenges
  • Figure 2: Global: Polymerase Chain Reaction Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Polymerase Chain Reaction Market: Breakup by Product (in %), 2023
  • Figure 4: Global: Polymerase Chain Reaction Market: Breakup by End User (in %), 2023
  • Figure 5: Global: Polymerase Chain Reaction Market: Breakup by Region (in %), 2023
  • Figure 6: Global: Polymerase Chain Reaction Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 7: Global: Polymerase Chain Reaction (Instruments) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 8: Global: Polymerase Chain Reaction (Instruments) Market: Breakup by Type (in %), 2023
  • Figure 9: Global: Polymerase Chain Reaction (Instruments- Standard PCR Systems) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Polymerase Chain Reaction (Instruments- Standard PCR Systems) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Polymerase Chain Reaction (Instruments- Digital PCR Systems) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Polymerase Chain Reaction (Instruments- Digital PCR Systems) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Polymerase Chain Reaction (Instruments- Real-Time PCR Systems) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Polymerase Chain Reaction (Instruments- Real-Time PCR Systems) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Polymerase Chain Reaction (Instruments) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Polymerase Chain Reaction (Reagents and Consumables) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Polymerase Chain Reaction (Reagents and Consumables) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Polymerase Chain Reaction (Software and Services) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Polymerase Chain Reaction (Software and Services) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Polymerase Chain Reaction (Academic and Research Institutes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Polymerase Chain Reaction (Academic and Research Institutes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Polymerase Chain Reaction (Clinical Diagnostics Labs and Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Polymerase Chain Reaction (Clinical Diagnostics Labs and Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Polymerase Chain Reaction (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Polymerase Chain Reaction (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Polymerase Chain Reaction (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Polymerase Chain Reaction (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: North America: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: North America: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: United States: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: United States: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Canada: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Canada: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Asia Pacific: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Asia Pacific: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: China: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: China: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Japan: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Japan: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: India: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: India: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: South Korea: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: South Korea: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Australia: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Australia: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Indonesia: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Indonesia: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Others: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Others: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Europe: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Europe: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Germany: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Germany: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: France: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: France: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: United Kingdom: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: United Kingdom: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Italy: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Italy: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Spain: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Spain: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Russia: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Russia: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Others: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Others: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Latin America: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Latin America: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Brazil: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Brazil: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Mexico: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Mexico: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Others: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Others: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Middle East and Africa: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Middle East and Africa: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Global: Polymerase Chain Reaction Industry: SWOT Analysis
  • Figure 77: Global: Polymerase Chain Reaction Industry: Value Chain Analysis
  • Figure 78: Global: Polymerase Chain Reaction Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Polymerase Chain Reaction Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Polymerase Chain Reaction Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 3: Global: Polymerase Chain Reaction Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 4: Global: Polymerase Chain Reaction Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 5: Global: Polymerase Chain Reaction Market Structure
  • Table 6: Global: Polymerase Chain Reaction Market: Key Players
目次
Product Code: SR112024A2315

The global polymerase chain reaction market size reached US$ 7.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 13.9 Billion by 2032, exhibiting a growth rate (CAGR) of 6.5% during 2024-2032.

Polymerase chain reaction (PCR) refers to a molecular diagnostic technique that is used to make multiple copies of a segment of DNA. A PCR machine is used to manipulate the temperature of the sample in an automatic and pre-programmed procedure to generate millions of copies of DNA sequencing accurately. This technology identifies and cultures disease-causing microorganisms, which aid in the detection of tuberculosis, Acquired Immunodeficiency Syndrome (AIDS), infections and Lyme disease. Owing to this, it finds extensive applications across various life science-related fields, such as genetics, biotechnology, molecular biology, drug discovery and clinical diagnostics.

Global Polymerase Chain Reaction Market Trends and Drivers:

The increasing prevalence of various infectious diseases and genetic disorders is one of the key factors driving the growth of the market. The rising geriatric population across the globe, which is more prone to chronic medical ailments, is also driving the industry growth. The outbreak of the coronavirus disease (COVID-19) pandemic has further led to the widespread adoption of PCR technologies for accurate diagnosis and early detection of infections. PCR devices also aid in minimizing the risks of contamination and the chances of human errors in the entire process.

The increasing demand for personalized and precision medicines is also creating a positive outlook for the market. These medicines aim to provide tailor-made therapies, which are identified and developed using PCR technologies. Other factors, including the increasing application in clinical diagnostics, along with extensive research and development (R&D) activities in the field of biotechnology, are expected to drive the market further.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global polymerase chain reaction market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on product and end user.

Breakup by Product:

Instruments

Standard PCR Systems

Digital PCR Systems

Real-Time PCR Systems

Reagents and Consumables

Software and Services

Breakup by End User:

Academic and Research Institutes

Clinical Diagnostics Labs and Hospitals

Pharmaceutical and Biotechnology Companies

Others

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Agilent Technologies Inc., BD (Becton, Dickinson and Company), BioMerieux (Institut Merieux SA), Bio-RAD Laboratories Inc., F. Hoffmann-La Roche AG, Fluidigm Corporation, Merck KGaA, Perkinelmer Inc., Promega Corporation, Takara Bio Inc. and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report:

  • How has the global polymerase chain reaction market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global polymerase chain reaction market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global polymerase chain reaction market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Polymerase Chain Reaction Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Instruments
    • 6.1.1 Market Trends
    • 6.1.2 Market Breakup by Type
      • 6.1.2.1 Standard PCR Systems
        • 6.1.2.1.1 Market Trends
        • 6.1.2.1.2 Market Forecast
      • 6.1.2.2 Digital PCR Systems
        • 6.1.2.2.1 Market Trends
        • 6.1.2.2.2 Market Forecast
      • 6.1.2.3 Real-Time PCR Systems
        • 6.1.2.3.1 Market Trends
        • 6.1.2.3.2 Market Forecast
    • 6.1.3 Market Forecast
  • 6.2 Reagents and Consumables
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Software and Services
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by End User

  • 7.1 Academic and Research Institutes
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Clinical Diagnostics Labs and Hospitals
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Pharmaceutical and Biotechnology Companies
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Agilent Technologies Inc.
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 BD (Becton, Dickinson and Company)
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
      • 13.3.2.3 Financials
      • 13.3.2.4 SWOT Analysis
    • 13.3.3 BioMerieux (Institut Merieux SA)
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 Financials
      • 13.3.3.4 SWOT Analysis
    • 13.3.4 Bio-RAD Laboratories Inc.
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 Financials
      • 13.3.4.4 SWOT Analysis
    • 13.3.5 F. Hoffmann-La Roche AG
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 Financials
    • 13.3.6 Fluidigm Corporation
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 Financials
    • 13.3.7 Merck KGaA
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
      • 13.3.7.3 Financials
      • 13.3.7.4 SWOT Analysis
    • 13.3.8 Perkinelmer Inc.
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 Financials
      • 13.3.8.4 SWOT Analysis
    • 13.3.9 Promega Corporation
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
    • 13.3.10 Takara Bio Inc.
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
      • 13.3.10.3 Financials
    • 13.3.11 Thermo Fisher Scientific Inc.
      • 13.3.11.1 Company Overview
      • 13.3.11.2 Product Portfolio
      • 13.3.11.3 Financials
      • 13.3.11.4 SWOT Analysis